Related Experiment Video

Updated: May 7, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Novel perspectives on dendritic cell-based immunotherapy of cancer

Irene Bonaccorsi1, Gaetana Pezzino, Barbara Morandi

  • 1Laboratory of Immunology and Biotherapy, Department Human Pathology, University of Messina, Italy; Cellular Therapy Program, University Hospital - A.O.U. Policlinico, Messina, Italy.

Immunology Letters
|October 1, 2013
PubMed

Insights

Dendritic cell (DC) vaccines show promise for cancer treatment. Overcoming current challenges requires a deeper understanding of DC biology, trafficking, and interactions for more effective cancer immunotherapies.

Area of Science:

  • Immunobiology
  • Cellular immunology
  • Cancer immunotherapy

Background:

  • Advances in dendritic cell (DC) biology and large-scale cell culture have positioned DCs as potential cancer vaccine agents.
  • Despite progress, significant challenges remain in developing effective DC-based cancer vaccines for human treatment.

Purpose of the Study:

  • To critically evaluate current limitations in dendritic cell vaccines for human cancer.
  • To emphasize the need for enhanced understanding of DC biology for improved vaccine efficacy.

Main Methods:

  • Review of recent immunobiology knowledge on dendritic cells.
  • Analysis of current cell culture techniques for dendritic cell generation.
  • Discussion of DC trafficking, functions, and innate immune cell interactions.

Main Results:

  • Current dendritic cell vaccines face several pitfalls in treating human cancer.
  • Understanding DC trafficking and interactions is crucial for vaccine development.

Conclusions:

  • Further research into dendritic cell trafficking, functions, and innate immune cell interactions is essential.
  • Improved knowledge is key to developing more effective dendritic cell vaccines for cancer treatment.
Keywords:
Cancer vaccinesCell interactionsDendritic cellsImmunotherapyLymph

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...